ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2672

Perceived Barriers to Mental Health Care Among Patients with Systemic Sclerosis: A Qualitative Study

Karima Becetti1, Laura Robbins2, Carol Mancuso3, Jessica K. Gordon1 and Robert F. Spiera1, 1Rheumatology, Hospital for Special Surgery, New York, NY, 2Education & Academic Affairs, Hospital for Special Surgery, New York, NY, 3Medicine, Hospital for Special Surgery, New York, NY

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: mental health and systemic sclerosis

  • Tweet
  • Email
  • Print
Session Information

Date: Tuesday, November 7, 2017

Title: Systemic Sclerosis, Fibrosing Syndromes and Raynaud's – Clinical Aspects and Therapeutics Poster III

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: Systemic Sclerosis (SSc) is characterized by disfigurement, morbidity, and increased mortality. The diagnosis carries significant psychosocial impact on patients, and many suffer with depression, anxiety, and body image distress. Interventions to address this impact are recommended as an essential aspect of care. However, previous studies identified mental health care as an unmet need for many SSc patients. Using a qualitative approach, this study aimed to evaluate perceived barriers to mental health care in SSc.

Methods: A qualitative study was conducted in a sample of consecutive SSc patients presenting to a single center. After obtaining informed consent, one-to-one interviews were conducted in-person using open-ended questions on individual patients’ experience with SSc and barriers to mental health care. Demographic and clinical data were obtained to characterize the study sample. A grounded theory approach was used to code interview transcripts and identify emergent concepts, categories, and themes. Interviews were continued until data saturation was reached.

Results: Twenty SSc patients with a median (range) age of 56.5 years (21-74) and disease duration of 4.5 years (1-34) were interviewed. 100% were female, 55% were white, 60% had private insurance, and 70% had diffuse SSc. Patients reported multiple psychological symptoms in association with SSc including sadness, anxiety, anger, uncertainty, and suicidal ideations at the time of diagnosis. Interview analysis identified four major themes relating to barriers to mental health care; patient-related, physician-related, system-related, and disease-specific factors (Figure 1). Patient-related factors included stigma about mental illness, avoidance of symptoms, fear of being vulnerable or burdening others, fear of other’s reaction, and lack of need due to available coping mechanisms. Lack of physicians’ rapport, empathy, and interest in emotional symptoms, and their subspecialty (non-mental health) emerged as barriers. System-related factors included high cost, lack of insurance, division within the healthcare system, and limited access and appointment time. Patients identified disease severity, physical limitations due to SSc, poor understanding of disease process, paucity of effective treatments, lack of SSc-specialized mental health services, and the numerous SSc-related appointments as barriers. The heterogeneity of SSc, variable patient experiences, and fear of contact with other patients with more aggressive disease were barriers to SSc group therapy.

 

Conclusion: In addition to the known barriers to mental health care such as access, cost, and stigma, SSc patients also identified disease-specific barriers. Identifying, understanding, and addressing these barriers are important for the effective dissemination of psychosocial interventions in this unique patient population.  

Figure 1. Conceptual framework

 


Disclosure: K. Becetti, None; L. Robbins, None; C. Mancuso, None; J. K. Gordon, Corbus Pharmaceuticals, 2,Cumberland Pharmaceuticals, 2,Bayer Pharmaceuticals, 2; R. F. Spiera, Roche-Genetech, 2,GSK, 2,BMS, 2,Celgene, 2,Boehringer Ingelheim, 2,Cytori, 2,Chemocentryx, 2,Corbus Pharmaceuticals, 2,Prism, 2,Roche-Genetech, 5,GSK, 5,Boehringer Ingelheim, 5.

To cite this abstract in AMA style:

Becetti K, Robbins L, Mancuso C, Gordon JK, Spiera RF. Perceived Barriers to Mental Health Care Among Patients with Systemic Sclerosis: A Qualitative Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/perceived-barriers-to-mental-health-care-among-patients-with-systemic-sclerosis-a-qualitative-study/. Accessed .
  • Tweet
  • Email
  • Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/perceived-barriers-to-mental-health-care-among-patients-with-systemic-sclerosis-a-qualitative-study/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology